Publication:
Research Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis

Simple item page
dc.contributor.authorTeri A. Manolioen_US
dc.contributor.authorCarolyn M. Hutteren_US
dc.contributor.authorMark Aviganen_US
dc.contributor.authorRicardo Cibottien_US
dc.contributor.authorRobert L. Davisen_US
dc.contributor.authorJoshua C. Dennyen_US
dc.contributor.authorLois La Grenadeen_US
dc.contributor.authorLisa M. Wheatleyen_US
dc.contributor.authorMary N. Carringtonen_US
dc.contributor.authorWasun Chantratitaen_US
dc.contributor.authorWen Hung Chungen_US
dc.contributor.authorAndrea D. Daltonen_US
dc.contributor.authorShuen Iu Hungen_US
dc.contributor.authorMing Ta Michael Leeen_US
dc.contributor.authorJ. Steven Leederen_US
dc.contributor.authorJuan J.L. Lertoraen_US
dc.contributor.authorSurakameth Mahasirimongkolen_US
dc.contributor.authorHoward L. McLeoden_US
dc.contributor.authorMaja Mockenhaupten_US
dc.contributor.authorMichael Pacanowskien_US
dc.contributor.authorElizabeth J. Phillipsen_US
dc.contributor.authorSimone Pinheiroen_US
dc.contributor.authorMunir Pirmohameden_US
dc.contributor.authorCynthia Sungen_US
dc.contributor.authorWimon Suwankesawongen_US
dc.contributor.authorLauren Trepanieren_US
dc.contributor.authorSanta J. Tumminiaen_US
dc.contributor.authorDavid Veenstraen_US
dc.contributor.authorRika Yuliwulandarien_US
dc.contributor.authorNeil H. Shearen_US
dc.contributor.otherLeidos Inc.en_US
dc.contributor.otherNational Yang-Ming University Taiwanen_US
dc.contributor.otherChang Gung Memorial Hospitalen_US
dc.contributor.otherUniversität Freiburg im Breisgauen_US
dc.contributor.otherUniversity of Wisconsin Madison, School of Veterinary Medicineen_US
dc.contributor.otherMassachusetts Institute of Technologyen_US
dc.contributor.otherThe Food and Drug Administration, Thailand Ministry of Public Healthen_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.contributor.otherChang Gung Universityen_US
dc.contributor.otherMurdoch Universityen_US
dc.contributor.otherChildren's Mercy Hospitals and Clinicsen_US
dc.contributor.otherNational Institute of Allergy and Infectious Diseasesen_US
dc.contributor.otherNational University of Singaporeen_US
dc.contributor.otherUniversity of Torontoen_US
dc.contributor.otherNIH Clinical Centeren_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherUniversity of Washington, Seattleen_US
dc.contributor.otherNational Human Genome Research Instituteen_US
dc.contributor.otherFood and Drug Administrationen_US
dc.contributor.otherGeisinger Health Systemen_US
dc.contributor.otherNational Eye Instituteen_US
dc.contributor.otherNational Institute of Arthritis and Musculoskeletal and Skin Diseasesen_US
dc.contributor.otherMoffitt Cancer Centeren_US
dc.contributor.otherVanderbilt Universityen_US
dc.contributor.otherUniversity of Tennessee Health Science Centeren_US
dc.contributor.otherStevens-Johnson Syndrome Foundationen_US
dc.contributor.otherYARSI Universityen_US
dc.date.accessioned2019-08-28T06:23:10Z
dc.date.available2019-08-28T06:23:10Z
dc.date.issued2018-03-01en_US
dc.description.abstract© 2017 American Society for Clinical Pharmacology and Therapeutics Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is one of the most devastating of adverse drug reactions (ADRs) and was, until recently, essentially unpredictable. With the discovery of several risk alleles for drug-induced SJS/TEN and the demonstration of effectiveness of screening in reducing incidence, the stage is set for implementation of preventive strategies in populations at risk. Yet much remains to be learned about this potentially fatal complication of commonly used drugs.en_US
dc.identifier.citationClinical Pharmacology and Therapeutics. Vol.103, No.3 (2018), 390-394en_US
dc.identifier.doi10.1002/cpt.890en_US
dc.identifier.issn15326535en_US
dc.identifier.issn00099236en_US
dc.identifier.other2-s2.0-85041800780en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46933
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041800780&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleResearch Directions in Genetic Predispositions to Stevens–Johnson Syndrome / Toxic Epidermal Necrolysisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041800780&origin=inwarden_US

Files

Collections

Scopus 2018